What's Going On With Spyre Therapeutics Stock On Wednesday? - Spyre Therapeutics (NASDAQ:SYRE)

Spyre Therapeutics falls 12% amid major insider stock sales. Explore the technical data and market sentiment for SYRE.

Raccontata dabenzinga.com